AQST
Price
$4.20
Change
-$0.17 (-3.89%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
383.26M
25 days until earnings call
TLRY
Price
$0.62
Change
+$0.01 (+1.64%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
1.87B
10 days until earnings call
Interact to see
Advertisement

AQST vs TLRY

Header iconAQST vs TLRY Comparison
Open Charts AQST vs TLRYBanner chart's image
Aquestive Therapeutics
Price$4.20
Change-$0.17 (-3.89%)
Volume$23.39K
Capitalization383.26M
Tilray Brands
Price$0.62
Change+$0.01 (+1.64%)
Volume$217.56K
Capitalization1.87B
AQST vs TLRY Comparison Chart in %
Loading...
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AQST vs. TLRY commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AQST is a Hold and TLRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (AQST: $4.37 vs. TLRY: $0.61)
Brand notoriety: AQST: Not notable vs. TLRY: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AQST: 111% vs. TLRY: 64%
Market capitalization -- AQST: $383.26M vs. TLRY: $1.87B
AQST [@Pharmaceuticals: Other] is valued at $383.26M. TLRY’s [@Pharmaceuticals: Other] market capitalization is $1.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AQST’s FA Score shows that 0 FA rating(s) are green whileTLRY’s FA Score has 0 green FA rating(s).

  • AQST’s FA Score: 0 green, 5 red.
  • TLRY’s FA Score: 0 green, 5 red.
According to our system of comparison, both AQST and TLRY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AQST’s TA Score shows that 3 TA indicator(s) are bullish while TLRY’s TA Score has 5 bullish TA indicator(s).

  • AQST’s TA Score: 3 bullish, 4 bearish.
  • TLRY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TLRY is a better buy in the short-term than AQST.

Price Growth

AQST (@Pharmaceuticals: Other) experienced а +8.44% price change this week, while TLRY (@Pharmaceuticals: Other) price change was -4.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was +5.79%, and the average quarterly price growth was +72.07%.

Reported Earning Dates

AQST is expected to report earnings on Nov 10, 2025.

TLRY is expected to report earnings on Oct 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.74% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY($1.87B) has a higher market cap than AQST($383M). AQST YTD gains are higher at: 22.753 vs. TLRY (-54.038). AQST has higher annual earnings (EBITDA): 1.18M vs. TLRY (-1.23B). TLRY has more cash in the bank: 260M vs. AQST (23.9M). AQST has less debt than TLRY: AQST (33.3M) vs TLRY (529M). TLRY has higher revenues than AQST: TLRY (700M) vs AQST (50.6M).
AQSTTLRYAQST / TLRY
Capitalization383M1.87B21%
EBITDA1.18M-1.23B-0%
Gain YTD22.753-54.038-42%
P/E RatioN/A8.52-
Revenue50.6M700M7%
Total Cash23.9M260M9%
Total Debt33.3M529M6%
FUNDAMENTALS RATINGS
AQST vs TLRY: Fundamental Ratings
AQST
TLRY
OUTLOOK RATING
1..100
2215
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
3947
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
9595

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AQST's Valuation (38) in the Pharmaceuticals Major industry is in the same range as TLRY (47) in the Biotechnology industry. This means that AQST’s stock grew similarly to TLRY’s over the last 12 months.

AQST's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as TLRY (100) in the Biotechnology industry. This means that AQST’s stock grew similarly to TLRY’s over the last 12 months.

TLRY's SMR Rating (96) in the Biotechnology industry is in the same range as AQST (100) in the Pharmaceuticals Major industry. This means that TLRY’s stock grew similarly to AQST’s over the last 12 months.

AQST's Price Growth Rating (39) in the Pharmaceuticals Major industry is in the same range as TLRY (47) in the Biotechnology industry. This means that AQST’s stock grew similarly to TLRY’s over the last 12 months.

TLRY's P/E Growth Rating (94) in the Biotechnology industry is in the same range as AQST (100) in the Pharmaceuticals Major industry. This means that TLRY’s stock grew similarly to AQST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AQSTTLRY
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BARDX8.330.07
+0.88%
iShares Developed Real Estate Idx Inv A
FMFAX89.40N/A
N/A
Fidelity Advisor Materials A
FTYCX44.24N/A
N/A
FullerThaler Behavioral Sm-Cp Eq C
OSCCX20.28N/A
N/A
Invesco Main Street Small Cap C
PSPFX4.38-0.02
-0.45%
US Global Investors Global Res

AQST and

Correlation & Price change

A.I.dvisor tells us that AQST and SCYX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AQST and SCYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AQST
1D Price
Change %
AQST100%
+8.44%
SCYX - AQST
33%
Poorly correlated
-2.63%
DERM - AQST
32%
Poorly correlated
+1.39%
TLRY - AQST
31%
Poorly correlated
+1.43%
OGI - AQST
31%
Poorly correlated
N/A
ESPR - AQST
31%
Poorly correlated
+10.71%
More

TLRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been closely correlated with SNDL. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if TLRY jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
+1.43%
SNDL - TLRY
76%
Closely correlated
+4.70%
CGC - TLRY
63%
Loosely correlated
+0.91%
OGI - TLRY
61%
Loosely correlated
N/A
CRON - TLRY
58%
Loosely correlated
+1.99%
ACB - TLRY
56%
Loosely correlated
+1.56%
More